Intelligent Ultrasound Group Plc (GB:IUG) has released an update.
Intelligent Ultrasound Group plc has announced a conditional agreement to sell its Clinical AI business to GE HealthCare for £40.5 million, retaining only the NeedleTrainer products. The deal, subject to shareholder and regulatory approval, is at a substantial premium to the company’s current share price. Shareholders have been assured of a material return of capital post-transaction, with strategic details to be disclosed upon completion, anticipated for September/October 2024.
For further insights into GB:IUG stock, check out TipRanks’ Stock Analysis page.
